646 related articles for article (PubMed ID: 17828529)
1. Locomotor response to levodopa in fluctuating Parkinson's disease.
Moore ST; MacDougall HG; Gracies JM; Ondo WG
Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
[TBL] [Abstract][Full Text] [Related]
2. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
[TBL] [Abstract][Full Text] [Related]
3. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
Ondo WG; Shinawi L; Moore S
Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
[TBL] [Abstract][Full Text] [Related]
4. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
[TBL] [Abstract][Full Text] [Related]
5. Gait variability in Parkinson's disease: levodopa and walking direction.
Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
[TBL] [Abstract][Full Text] [Related]
6. Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease.
Caliandro P; Ferrarin M; Cioni M; Bentivoglio AR; Minciotti I; D'Urso PI; Tonali PA; Padua L
Gait Posture; 2011 Mar; 33(3):436-41. PubMed ID: 21256751
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in the stride length-cadence relation in parkinsonian gait.
Morris M; Iansek R; Matyas T; Summers J
Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
[TBL] [Abstract][Full Text] [Related]
8. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.
Elia AE; Dollenz C; Soliveri P; Albanese A
Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174
[TBL] [Abstract][Full Text] [Related]
9. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
[TBL] [Abstract][Full Text] [Related]
10. Effects of levodopa on upper limb mobility and gait in Parkinson's disease.
Vokaer M; Azar NA; de Beyl DZ
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1304-7. PubMed ID: 12933941
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
[TBL] [Abstract][Full Text] [Related]
12. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
[TBL] [Abstract][Full Text] [Related]
13. Levodopa effect upon functional balance of Parkinson's disease patients.
Nova IC; Perracini MR; Ferraz HB
Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
[TBL] [Abstract][Full Text] [Related]
14. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
15. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
[TBL] [Abstract][Full Text] [Related]
16. Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Tan EK; Ratnagopal P; Han SY; Wong MC
Acta Neurol Scand; 2003 Mar; 107(3):202-6. PubMed ID: 12614313
[TBL] [Abstract][Full Text] [Related]
17. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
[TBL] [Abstract][Full Text] [Related]
18. Objective Gait and Balance Impairments Relate to Balance Confidence and Perceived Mobility in People With Parkinson Disease.
Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
Phys Ther; 2016 Nov; 96(11):1734-1743. PubMed ID: 27149959
[TBL] [Abstract][Full Text] [Related]
19. Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.
Vieregge P; Stolze H; Klein C; Heberlein I
J Neural Transm (Vienna); 1997; 104(2-3):237-48. PubMed ID: 9203085
[TBL] [Abstract][Full Text] [Related]
20. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
